Loading...
Epcoritamab
Pida mas información
935106861
info@markelab.com
Precio
387.5€ (100 µg)
proveedor
Abbexareference
abx831545Tested Applications
ELISA, WBreactivity
Humanstatus
This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications (RUOclonality
MonoclonalDescripción
Epcoritamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD3E/MS4A1/CD20, Epcoritamab (DuoBody®-CD3xCD20) is a proprietary bispecific antibody created using Genmab’s DuoBody technology. It targets CD20 on the B-cells, a clinically well-validated target that is expressed in a wide variety of B-cell malignancies. Epcoritamab is currently under investigation in a Phase I/II study for multiple hematological B cell malignancies.
Características del producto
category
Biosimilars
host
Human
clonality
Monoclonal
reactivity
Human
immunogen target
CD3E/MS4A1/CD20
host
Human
isotype
IgG4 Kappa-Lambda
conjugation
Unconjugated
form
Liquid
tested applications
ELISA, WB
size 1
100 µg
size 2
1 mg
expression
Recombinant
purity
> 95%
purification
Purified from cell culture supernatants by Protein A/G chromatography.
buffer
0.01 M PBS. pH 7.4.
storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
dry ice
No
availability
Shipped within 7-12 working days.
alias
Biosimilars
Quizá le pueda interesar
Goat MAP28 ELISA Kit
proveedor
FineTestreference
EG0012reactivity
goatstatus
RUOPrecio a consultar
Ver másHRP conjugated Streptavidin
proveedor
FineTestreference
FNSA-0001Tested Applications
ELISA, WBstatus
RUOPrecio a consultar
Ver másHRP conjugated Goat Anti-Mouse FC
proveedor
FineTestreference
FNSA-0002Tested Applications
ELISA, WBreactivity
mousestatus
RUOPrecio a consultar
Ver más